In today’s session TESARO Inc (TSRO) registered an unusually high (1,489) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the October, 2016 call, expecting serious TSRO increase. With 1,489 contracts traded and 17384 open interest for the Oct, 16 contract, it seems this is a quite bullish bet. The option with symbol: TSRO161021C00110000 closed last at: $4.4 or 2.2% down. The stock decreased 1.66% or $1.67 during the last trading session, hitting $98.87. About 1.14M shares traded hands. TESARO Inc (NASDAQ:TSRO) has risen 120.54% since March 2, 2016 and is uptrending. It has outperformed by 111.30% the S&P500.
Analysts await TESARO Inc (NASDAQ:TSRO) to report earnings on November, 3. They expect $-1.92 earnings per share, down 15.66% or $0.26 from last year’s $-1.66 per share. After $-1.28 actual earnings per share reported by TESARO Inc for the previous quarter, Wall Street now forecasts 50.00% negative EPS growth.
TESARO Inc (NASDAQ:TSRO) Ratings Coverage
Out of 12 analysts covering Tesaro Inc (NASDAQ:TSRO), 10 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 83% are positive. Tesaro Inc has been the topic of 15 analyst reports since August 24, 2015 according to StockzIntelligence Inc. The stock of TESARO Inc (NASDAQ:TSRO) earned “Outperform” rating by FBR Capital on Wednesday, June 29. Wedbush maintained TESARO Inc (NASDAQ:TSRO) rating on Friday, August 5. Wedbush has “Outperform” rating and $107 price target. The firm earned “Buy” rating on Friday, February 5 by Lake Street. Wells Fargo initiated the stock with “Outperform” rating in Friday, December 4 report. The stock has “Buy” rating given by Citigroup on Thursday, March 17. On Monday, August 24 the stock rating was initiated by Leerink Swann with “Outperform”. The company was initiated on Tuesday, September 1 by Raymond James. The firm has “Outperform” rating by Robert W. Baird given on Tuesday, July 19. The rating was maintained by Mizuho with “Buy” on Friday, August 5. The firm earned “Outperform” rating on Friday, May 13 by Credit Suisse.
Insitutional Activity: The institutional sentiment increased to 1.55 in Q2 2016. Its up 0.32, from 1.23 in 2016Q1. The ratio increased, as 24 funds sold all TESARO Inc shares owned while 36 reduced positions. 34 funds bought stakes while 59 increased positions. They now own 44.90 million shares or 3.32% less from 46.44 million shares in 2016Q1.
Eventide Asset Limited Liability last reported 0.46% of its portfolio in the stock. Passport Cap Ltd Liability has invested 1.13% of its portfolio in TESARO Inc (NASDAQ:TSRO). Franklin Resources has 494,900 shares for 0.02% of their US portfolio. The Connecticut-based Quantitative Systematic Strategies Limited Liability Com has invested 0.11% in TESARO Inc (NASDAQ:TSRO). The New York-based Amalgamated Comml Bank has invested 0.02% in TESARO Inc (NASDAQ:TSRO). Goldman Sachs Grp Incorporated holds 0% or 133,157 shares in its portfolio. Jennison Associates Ltd Liability has invested 0.07% of its portfolio in TESARO Inc (NASDAQ:TSRO). Suffolk Management Limited Liability Company holds 2.29% or 211,427 shares in its portfolio. The Hong Kong-based Parametrica Mgmt Limited has invested 1.76% in TESARO Inc (NASDAQ:TSRO). Whittier Tru Of Nevada owns 400 shares or 0% of their US portfolio. Pacad Invest holds 0.03% or 2,800 shares in its portfolio. Royal Bancorp Of Canada holds 0% of its portfolio in TESARO Inc (NASDAQ:TSRO) for 8,759 shares. Teachers Retirement Systems Of The State Of Kentucky last reported 15,135 shares in the company. Blackrock Institutional Tru Co Na owns 719,297 shares or 0.01% of their US portfolio. Moreover, Cormorant Asset Ltd Liability has 4.33% invested in TESARO Inc (NASDAQ:TSRO) for 362,875 shares.
Insider Transactions: Since June 10, 2016, the stock had 0 insider purchases, and 5 selling transactions for $4.39 million net activity. Another trade for 408 shares valued at $44,113 was sold by Huber Martin H. Jr.. Hanke Jeffrey H. sold $2.51 million worth of stock or 29,166 shares. Shares for $285,274 were sold by English Edward C on Friday, June 10.
TESARO, Inc. is an oncology-focused biopharmaceutical company. The company has a market cap of $5.09 billion. The Firm acquires, in-licenses and develops oncology product candidates. It currently has negative earnings. It operates in business of developing and commercializing oncology-focused therapeutics segment.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.